Addiction Psychiatry Residency Program
(PGY-V and above)
Yale Drug and Alcohol Abuse Specialty Programs were ranked #1 by US News and World Report 2014.
The Addiction Psychiatry Residency Training Program at Yale University School of Medicine is a well-established (since 1996), nationally recognized residency program with an outstanding and diverse faculty. The program accepts 7 board-eligible psychiatric residents each year for a one-year training program.
The purpose of the Addiction Psychiatry Residency Program is to provide advanced training in the evaluation, treatment, research, and teaching of substance-related disorders. In addition, trainees will be fully trained in techniques required in the treatment of patients with dual diagnosis, specifically those with substance-related and comorbid psychiatric disorders. The goals of the program are to develop the skills, knowledge and competencies needed to:
- Understand the basic science and clinical science medical knowledge needed to care for patients with substance-related disorders.
- Provide outstanding patient care to relieve the suffering of patients with substance-related disorders.
- Effectively demonstrate interpersonal communication skills with patients, their families and others caring for the patient.
- Understand and implement professional responsibilities to patients with substance-related disorders, their families, to colleagues, to the profession, the department of psychiatry, the community and society.
- Assess practices and utilized advanced learning skills in order to stay current with evidence based approaches to patient care.
- Utilize resources in the system effectively, and to be able to advocate for improvement in the system of care.
- Lead in the development and dissemination of knowledge in the field of addiction psychiatry.
At the end of the training year, the addiction psychiatry resident will be well-prepared to sit for the specialty board examination, function independently and to enter practice without supervision as an addiction psychiatrist at the consultant level.